The Non Surgical Side of RetinaView Issue
Three Pillars of Success in Patient and Practice Management Strategies in Diabetic Macular Edema
Supported via advertising by Alimera Sciences and Optos
AMD Disease Education Resource Center: Efficacy and Tolerability of Intravitreal Aflibercept in Patients With Exudative AMD Previously Treated With Ranibizumab or Bevacizumab
Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec
An Update on the Latest Clinical Trials in Diabetic Macular Edema
Supported via advertising by Regeneron and Notal Vision
AMD in 2016: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy
Supported by an educational grant from Regeneron Pharmaceuticals.
July/August 2016 | Medical Editors' Page
CATT 5-Year Data: Our Perspective
Allen C. Ho, MD, and Robert L. Avery, MD
July/August 2016 | business Of Retina pa Avenue Updates
Hacking the EpicCare Electronic Health Record System
How to make this widely used EHR system more efficient for high-volume vitreoretinal surgeons.
William J. Foster, MD, PhD, and David Fleece, MD
July/August 2016 | innovations In Retina
Visual Function Biomarkers Needed for Dry AMD
Early detection may allow treatment and possible reversal. Part 1 of a 2-part series.
July/August 2016 | fellows' Focus
Building and Maintaining a Referral Base
Tips for newly graduated fellows.
Murtaza Adam, MD
July/August 2016 | coding For Retina
A Potpourri of Complicated Surgical Coding Cases
These coding tips and examples can help minimize common problems related to claim denials.
Riva Lee Asbell
July/August 2016 | retina Surgery Retina Pearls
Macular Hole Repair Using an ILM Patch
Concept of ILM flap or patch for use in challenging cases.
Brian C. Joondeph, MD, MPS
July/August 2016 | global Perspectives
Removal of Hydrogel Scleral Buckles
Surgery to remove these devices must involve caution due to risk of complications.
Niels Crama, MD
July/August 2016 | Medical Retina
The Burden of Noninfectious Uveitis of the Posterior Segment: A Review
New pharmacologic treatment options are urgently needed.
Steven Yeh, MD, and Jessica G. Shantha, MD
July/August 2016 | Special Focus: Ocular Oncology
Which Tumor, What Imaging Modality?
Play your cards right and make the best bet for tumor diagnosis.
Carol L. Shields, MD; Kareem Sioufi, MD; Timothy Fuller, MD; Timothy Higgins, BS; Sandor R. Ferenczy, CRA; and Jerry A. Shields, MD
Intraarterial Chemotherapy for Retinoblastoma
History, technique, and update on outcomes.
Ryan S. Kim, BA; Mark J. Dannenbaum, MD; and Amy C. Schefler, MD
July/August 2016 | Cover Focus: The Nonsurgical Side Of Retina
Profile of a Medical Retina Specialist
Shedding light on a new breed of clinicians.
Jordana G. Fein, MD, MS, and Heeral R. Shah, MD
The Promise of Integrin Receptors for Treating Vitreoretinal Disorders
Study results suggest this class of drug has vitreolytic activity and a longer duration of effect than current treatments.
Victor H. Gonzalez, MD
The Role of Laser in the Pharmacologic Era of Retina
Laser still plays a prominent part in managing retinal pathologies, and innovations in laser delivery suggest potential areas where indications might be expanded.
Baruch Kuppermann, MD, PhD
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
Improving Outcomes in Neovascular AMD With Combination Intravitreal Therapy
Could an anti-PDGF drug work with an anti-VEGF agent to provide better antiangiogenic effect than anti-VEGF monotherapy?
Jeffrey S. Heier, MD
Combination Therapy for Neovascular AMD
Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell.
Glenn J. Jaffe, MD
Other Anti-VEGF/Anti-PDGF Combination Drugs in the Pipeline for Treatment of AMD
the staff of Retina Today
July/August 2016 | Departments
5Q With Ehsan Rahimy, MD
Ehsan Rahimy, MD, is a Surgical and Medical Vitreoretinal Specialist at the Palo Alto Medical Foundation in Palo Alto, Calif.
July/August 2016 | Web Exclusive
Eric Suhler, MD, MPH, and Thomas Albini, MD